Manufacturing Equipment, Upstream Processing

Ensuring Cell Line Stability for Protein Therapeutics

September 26, 2024

Stable cell line development can benefit from applying integrated analytical technologies.

Optimizing Expression Systems for AAV Vectors

August 09, 2024

Optimizing AAV vector manufacturing will be necessary to meet anticipated future market demand.

Freudenberg Adds Custom Single-Use Assemblies to Biopharma Product Portfolio

August 05, 2024

Freudenberg Medical now offers custom single-use assemblies to expand its offerings in silicone extrusion and molding for biopharma applications.

Univercells Expands Collaboration with University of Pennsylvania for Gene Therapy Manufacturing

July 24, 2024

Under the expanded agreement, Univercells and University of Pennsylvania will evaluate certain bioreactors for scalable gene therapy production.

AGC Biologics Doubles Single-Use Bioreactor Capacity with Expansion at Denmark Site

June 11, 2024

AGC Biologics has completed an expansion at its Copenhagen, Denmark, site, which doubles its bioreactor capacity for mammalian-based cell culture.

Exploring Innovative Engineering Design to Address Upstream Bioprocessing Complications (INTERPHEX 2024)

May 03, 2024

Global product manager at Cytiva, Eric Corti, discusses the challenges with designing a new single-use mixing system that ensures leak-free fluid handling operations at INTERPHEX 2024.

Evaluating Uses for Both Single-Use and Stainless-Steel Bioreactors

April 02, 2024

Despite a growing trend toward single-use bioreactors, stainless-steel retains its relevance for certain products.

Milestone Approval to Steady Stream, Gene Editing Revs Up

February 02, 2024

The milestone approval of a gene-edited therapeutic paves the way for gene-editing technologies.

Abzena Launches New Cell Line Development Platforms

January 22, 2024

Abzena has launched its AbZelect platforms, designed for improving cell line development.

Right the First Time: Bioreactor Scale and Design Translation

January 02, 2024

The authors give an overview of scaling approaches and present good scaling practices for the biopharma industry.